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E
nterovirus 71 (EV71) and coxsackievirus (CV) are the major causative agents of hand-foot-and-mouth disease in mainland China (29) . These pathogens have caused over one million human cases and nine hundred deaths in 2010 (Ministry of Health of the People's Republic of China; http://www.moh.gov.cn/publicfiles /business/htmlfiles/mohjbyfkzj/s3578/201102/50646.htm). EV71 causes severe aseptic meningitis, encephalitis, myocarditis, acute flaccid paralysis, and pulmonary edema, which lead to high fatality rates (28, 29) . In particular, young children are more susceptible to EV71 infection (2, 24) .
EV71 belongs to the Enterovirus genus, family Picornaviridae. The virus possesses a 7,400-nucleotide single-stranded, positivesense RNA genome (9, 12) . The genomic RNA contains long 5= untranslated regions (5=-UTR), a single open reading frame, and a polyadenylated 3=-UTR. The 5=-end uridine of the viral genome is covalently linked to the hydroxyl group of Tyr, which is located at the third position of the viral protein VPg. The open reading frame of EV71 encodes a 250-kDa polyprotein (16, 23) . The polyprotein is initially processed into one structural (P1) and two nonstructural (P2 and P3) regions, which are further cleaved into various precursors and 11 mature proteins, i.e., VP1 to VP4, 2A to 2C, and 3A to 3D. This polyprotein processing is mediated by the protease precursor 3CD and two mature proteases (2A and 3C). The 3D polymerase (3D pol ) protein functions as an RNA-dependent RNA polymerase (RdRp) that is essential for viral RNA synthesis (26) .
Picornavirus RNA replication is initiated by the genomic RNA covalently linked to a virally encoded nonstructural protein, 3B, also known as VPg (1) . VPg, a virally encoded protein with 20 to 22 amino acids, is covalently linked to the 5= end of picornavirus RNA (1) because VPg and uridylylated forms of VPg (VPg-pUpU) prime the initiation of RNA replication. During the initiation of viral RNA synthesis, 3D pol uses UTP and the conserved Tyr3 of VPg as a primer to perform uridylylation to form VPg-pUpU (7, 15) . The replication of the picornavirus genome uses the plus strand as a template to synthesize the minus strand, which, in turn, is used as a template for the production of excess plus strands, during which the synthesis of both plus and minus RNA strands is primed by VPg-pUpU. Although the VPg uridylylation can be used as a template by the poly(A) tail (15), later results revealed that an internal cis-acting replication element (CRE) with an RNA stem-loop structure in the 2C-coding region of the PV genome is capable of performing template production of VPg-pUpU with much more efficiency (15, 20) . CRE is present in the 2C-coding region of human enterovirus species A, B, C, and D, including EV71 (5), although the positions of this element in the genome significantly differ among different picornavirus genera (19) . Al-though CRE is essential for genome replication, researchers have suggested that it is required only for production of primers for plus-strand synthesis (13) . However, other studies have suggested that CRE-derived primers are required for both plus-and minusstrand syntheses (20, 22) . Moreover, the VPg uridylylation is stimulated by the viral precursor protein 3CD (14, 18) . Based on biochemical analysis, members of the Cameron laboratory proposed that two 3CD molecules bind the CRE stem and stimulate VPg uridylylation, presumably through the interactions of 3CD with 3D pol (14) . Notably, although CRE is essential for picornavirus replication, the precise CRE sequence of EV71 has not yet been experimentally defined and has been predicted to share similarity only with those of other enteroviruses by analysis of the primary sequence homologies with other picornavirus members (5) .
Although the biochemical analysis provided insight into the VPg uridylylation process, a few aspects of this process, such as the binding sites of VPg in 3D pol or 3CD and the precise mechanism that shows significant variation, remain uncertain. Crystal structure studies combined with the biochemical assays showed two distinct VPg binding sites on 3D
pol from foot-and-mouth disease virus (FMDV) and CVB3 (6, 8) by using an in vitro VPg uridylylation assay and polymerase, VPg peptide, and poly(rA) as the template. The crystal structure of FMDV 3D
pol -VPg1-UTPoligoA complex VPg1 fits in the RNA binding cleft of the polymerase and projects Tyr3 into the active site of 3D pol . VPg1 specifically binds to the F motif of the finger domain and helix ␣13 of the thumb domain, which span residues E166, I167, R168, K172, R179, T407, A410, and I411; mutations of these amino acids dramatically reduced the uridylylation activity of 3D pol (6) . Such VPg1 binding (at the catalytic site of 3D pol ) and the direct VPg-UMP interaction suggest a cis mechanism for FMDV VPg uridylylation in which VPg1 is directly uridylylated by its bound 3D pol (6) . In contrast, the structure of CVB3 3D pol -VPg-PPi (the pyrophosphate moiety from 3=dUTP) complex showed that VPg is bound at the base of the thumb subdomain of 3D pol (8) . VPg interacts with the P222, W369, T370, Y378-E383, V389, V392, and P394 residues of 3D pol . In the CVB3 3D pol -VPg structure, amino acid Tyr3 of VPg is far from the polymerase active site of the bound 3D pol . The CVB3 structural information, together with studies on poliovirus VPg uridylylation (11, 21) 
MATERIALS AND METHODS
Cells, viruses, and antibodies. African green monkey kidney cells (Vero) were cultured in Dulbecco's modified Eagle's medium (DMEM) (3) with 10% fetal bovine serum, 100 U/ml penicillin, and 100 g/ml streptomycin in 5% CO 2 Site-directed mutagenesis, expression, and purification of EV71 polymerase with mutations. Mutagenesis was performed with a pGEX-6P-1 expression vector containing the EV71 3D pol . Specific mutations were engineered into the EV71 3D pol expression plasmid with an Easy site-directed mutagenesis kit (Transgen, Beijing, People's Republic of China) as described previously (27) . The complete sequence of each EV71 3D pol gene with a mutation was validated by DNA sequencing. The wt and mutant forms of EV71 3D pol were purified as previously described (26) . For protein expression, Escherichia coli strain BL21(DE3) bearing the expression plasmid was grown at 37°C to an absorbance of 0.8 at 600 nm, induced with 0.1 mM isopropyl ␤-D-1-thiogalactopyranoside at 16°C for 20 h and harvested by centrifugation. Cells were resuspended and homogenized using a low-temperature ultra-high-pressure cell disrupter (JNBIO; Guangzhou, People's Republic of China) and lysis buffer containing 20 mM Tris-HCl (pH 8.0), 500 mM NaCl, 1 mM dithiothreitol (DTT), and 0.1 mM EDTA. The lysate was reclaimed after centrifugation at 20,000 ϫg for 30 min and loaded onto a glutathione-Sepharose column (GE Healthcare). After being washed with 20 mM Tris-HCl (pH 8.0), 500 mM NaCl, and 1 mM DTT, the glutathione S-transferase (GST) moiety was cleaved overnight with His-tagged tobacco etch virus (TEV) protease at 4°C. The elution was loaded into an Ni 2ϩ -nitrilotriacetic acid (NTA) agarose column (Qiagen) to eliminate the His-tagged TEV protease and then eluted by ultrafiltration into a buffer containing 20 mM Tris-HCl (pH 8.0), 15% glycerol, 100 mM NaCl, and 1 mM DTT. The sample was further purified using a ResourceQ column (GE Healthcare) with a linear gradient of from 0 mM to 350 mM NaCl with 20 mM Tris-HCl (pH 8.0), 15% glycerol, and 1 mM DTT. The target proteins were concentrated to 10 mg/ml in a buffer containing 20 mM Tris-HCl (pH 8.0), 300 mM NaCl, and 14% glycerol for storage and enzymatic assay.
GST-VPg 3D pol pulldown assay. Glutathione-Sepharose beads (wet volume ϭ 15 l) coupled with approximately 5 g of the purified GSTVPg were incubated for 30 min at 4°C with phosphate-buffered saline (PBS), which contains 137 mM NaCl, 2.7 mM KCl, 10 mM Na 2 HPO 4 , and 2 mM KH 2 PO 4 . The GST-VPg beads were incubated for 30 min at 4°C with 2 g of the wt EV71 3D pol or the EV71 3D pol mutants. After the beads were washed four times with 1 ml of PBS, proteins bound to the beads were analyzed with 12% SDS-PAGE and stained with Coomassie blue.
In vitro VPg uridylylation assay. The uridylylation assay mixture (20 l), containing 50 mM HEPES (pH 7.5), 0.5 mM magnesium chloride, 7% glycerol, 1 g of poly(A), 50 M VPg, 1 g of EV71 3D
pol (wt or mutants), and 1 Ci [␣-32 P]UTP, was incubated at 30°C for 1 h. After the reaction, the aliquots were mixed with the same volume of 2ϫ Tris-Tricine SDS buffer containing 100 mM Tris-HCl (pH 6.8), 20% (vol/vol) glycerol, 8% (wt/vol) SDS, 5% ␤-mercaptoethanol, and 0.05% bromophenol blue. Tris-Tricine SDS-PAGE, using a 4% stacking gel ( RNA elongation assay. The detailed protocols for the RNA elongation of EV71 3D pol have been previously reported (26) . The reaction mixtures, containing 20 nM wt EV71 3D pol or the polymerase with relevant mutants, 0.01 g of the poly(A) template (300 nucleotides in average length), 0.005 g of oligo(dT) (15) , 50 mM HEPES (pH 7.5), 25 M UTP, 4 mM DTT, 1.5 mM MgCl 2 , 60 M ZnCl 2 , 0.01% NP-40, and 0.01 Ci of [␣-32 P]UTP, were processed in a final volume of 50 l. The reactions were initiated by the addition of the enzyme, and the reaction mixtures were incubated at room temperature. The reactions were quenched at 10-min intervals by adding the samples directly onto DEAE filtermat papers (Wallac-PE Life Sciences). The unincorporated triphosphate was removed by washing the filters with 2ϫ saline-sodium citrate buffer. The amount of radiolabeled RNA bound to the membrane was quantified using Phosphorimager and IMAGEQUANT TL software.
Engineering 3D pol mutations into an infectious EV71 cDNA clone. EV71 genome-length cDNA clones with different mutations were constructed using pACYC-EV71. Shuttle vector pUC19-3D pol was used to engineer the mutations. This vector was constructed by engineering the SpeI-HindIII fragment of EV71 [representing nucleotides from position 5878 to the 3= end with a poly(A) tail that includes the complete 3D coding region] into the pUC19 plasmid. An Easy site-directed mutagenesis kit (Transgen, Beijing) was used to engineer all mutations into the shuttle vector pUC19-3D
pol . The DNA fragments with different mutations were then pasted back into pACYC-EV71 at the SpeI and HindIII sites.
RNA transcription and transfection. Genome-length wt and mutant viral RNAs were transcribed from the HindIII-linearized cDNA plasmids using a MEGAscript T7 kit (Ambion). The transcription reactions were performed according to the manufacturer's protocols. For transfection, approximately 5 g of RNA was electroporated into 8 ϫ 10 6 Vero cells in 0.8 ml of ice-cold PBS buffer (pH 7.5) using a 0.4-cm-gap cuvette with GenePulser (Bio-Rad) at 0.85 kV and 25 F, pulsing thrice at 3-s intervals. After a 10-min recovery at room temperature, the transfected cells were diluted in 25 ml DMEM containing 10% fetal calf serum (FCS) and were transferred into a T-150 flask and incubated at 37°C with 5% CO 2 . The viruses in the culture fluids were collected 48 h posttransfection (p.t.). Aliquots of the viruses were stored at Ϫ80°C.
Plaque assay. A series of 1:10 dilutions were prepared by mixing 15 l of the virus sample with 135 l DMEM-10% FCS. About 100 l of each dilution was seeded onto each well of 12-well plates containing confluent Vero cells (2 ϫ 10 5 cells per well, plated 1 day in advance). The plates were incubated at 37°C with 5% CO 2 for 1 h before the agar layer was added. After 4 days of incubation at 37°C with 5% CO 2 , the cells were fixed in 1% formaldehyde-methanol and then stained with 0.5% crystal violet. Plaque morphologies and numbers were recorded after the plates were washed with tap water.
Immunofluorescence assay (IFA). Vero cells transfected with the EV71 genome-length RNA were seeded on a Chamber Slide (Nalge Nunc). At 48 h p.t., the cells were fixed with Ϫ20°C 5% acetic acid in methanol for 20 min at room temperature. The fixed cells were washed with PBS and incubated with EV71 VP1 polyclonal antibody (1:300 dilution with PBS) for 1 h. After three washings with PBS, the cells were incubated for 1 h with FITC-conjugated goat anti-rabbit IgG at room temperature. After being subjected to washing three times with PBS, the slide was mounted with 90% glycerol and examined under a fluorescence microscope. Cell images were taken at ϫ200 magnification.
RESULTS

Sequence and structural variation of VPg binding on 3D
pol among different picornaviruses. Biochemical and structural studies have identified two VPg binding sites on 3D pol among different picornaviruses (6, 8, 11, 21) . FMDV VPg1 binds to the RNA tunnel of 3D pol , and Tyr3 of VPg is positioned next to the polymerase active site for uridylylation (Fig. 1A) . CVB3 VPg binds to 3D
pol at the base of the thumb subdomain, whereas VPg is far from the polymerase active site (Fig. 1A) . Sequence analysis indicates that amino acids critical for polymerase activity (e.g., residues involved in the catalytic reaction) are conserved among various picornaviruses (Fig. 1B) . However, residues involved in the CVB3 VPg binding are less conserved, which suggests variations in VPg binding among different picornaviruses. Structural and sequence analysis prompted an exploration of how VPg interacts with 3D pol in EV71. We hypothesized that, as seen with the CVB3 VPg binding site, EV71 VPg binds to 3D pol through the less-conserved amino acids on the surface of the polymerase. To test this hypothesis, systematic mutagenesis of the less-conserved, solvent-exposed regions on the 3D pol molecule was performed (Fig. 1B and C) . Five sites, including amino acids 71 to 80 (named Site-71), 131 to 140 (Site-131), 261 to 270 (Site-261), 311 to 317 (Site-311), and 361 to 370 (Site-361), were selected. On the crystal structure of EV71 3D pol (26) , Site-131 is located in the finger subdomain, whereas the other selected sites are located at the palm subdomain (Fig. 1C) . A panel of recombinant 3D
pol proteins that contain individual Ala substitutions at selected sites were expressed and purified. A total of 13 mutants, two or three from each site (Fig. 1D ), were prepared and tested for uridylylation activity.
Site-311 is critical for EV71 VPg uridylylation. Among the five selected sites on 3D pol , only mutations at Site-131 dramatically affected EV71 VPg uridylylation (Fig. 2) . Mutations at other sites did not significantly affect uridylylation activity (data not shown). For Site-131 mutants, substitution of T313A, F314A, or I317A reduced the wt VPg uridylylation activity by Ͼ90%. Mutant I311A retained approximately 45% of the wt activity. In contrast, the K312A, K315A, and G316A mutants exhibited uridylylation activity that was similar to or greater than that of the wt 3D pol . As a negative control, substitution of both D238A and D238E at the polymerase active site abolished the uridylylation activity (Fig. 2) . The results demonstrate that residues I311, T313, F314, and I317 in Site-311 are important for EV71 VPg uridylylation.
Site-311 does not function in viral RNA elongation. The mutational effect of Site-311 on VPg uridylylation results from two functional routes, namely, viral polymerase activity and VPg binding to 3D pol . Given that Site-311 is far from the polymerase catalytic residues, it is unlikely to participate directly in RNA polymerase activity. Hence, the Site-311 mutants were analyzed using an RNA elongation assay. As shown in Fig. 3 , all mutants retained Ͼ90% of the wt RNA elongation activity. The T313A mutant exhibited greater RNA elongation activity than the wt 3D pol , possibly because the T313A mutation indirectly affected the conformation of the polymerase active site region. As a control, the polymerase active site mutant D238A did not show any polymerase activity. These results indicate that the observed defect in VPg uridylylation is not due to the mutational effect on the viral RNA polymerase activity.
Mutations of Site-311 decrease VPg-3D pol interaction. We examined whether the Site-311 mutations affected VPg uridylylation by decreasing the interaction between EV71 3D pol and VPg. Hence, a GST-VPg fusion protein was used to pull down the wt and various 3D pol mutants. An equal amount of GST-VPg pulled down smaller amounts of I311A, T313A, F314A, and I317A mutant 3D pol than the wt 3D pol (Fig. 4A) , which indicates that these residues are important for VPg-3D pol interaction. In contrast, GST-VPg pulled down similar amounts of mutants K312A, K315A, and G316A, as well as the wt 3D pol , which suggests that the side chains of these residues are not involved in VPg binding. However, this phenomenon does not exclude the possibility that the main chain atoms of residues K312, K315, and G316 participate in VPg-3D pol binding. Collectively, the results demonstrate that Site-311 contributes to VPg binding to EV71 3D
pol . Site-311 is essential for EV71 replication. To demonstrate the biological relevance of Site-311 in viral replication, we engineered Site-311 mutations into an infectious cDNA clone of an epidemic strain of EV71. Equal amounts of the wt and the mutant genomelength RNA were electroporated into Vero cells. Transfected cells were monitored for viral protein synthesis and virus yield using a plaque assay (Fig. 5) . At 48 h p.t., IFA (detecting expression of viral VP1 protein) showed similar percentages of IFA-positive cells upon transfection with the RNAs of the wt and mutants K312A, K315A, and G316A. In contrast, mutants I311A, T313A, F314A, and I317A did not generate any IFA-positive cells at 48 h p.t.
Culture fluids collected at 48 h p.t. were measured for infectious viruses using a plaque assay. No infectious virus was recovered from the cells transfected with RNAs of mutants I311A, T313A, F314A, and I317A, whereas the cells transfected with mutants K312A, K315A, and G316A yielded smaller amounts of infectious viruses than those transfected with the wt RNA (Fig. 2) . Sequencing of the recovered viruses confirmed that the engineered mutations were retained (data not shown). Similar plaque morphologies were observed for the wt and the K312A, K315A, and G316A mutant viruses. As a negative control, EV71 cDNA containing the polymerase active site mutation D328A was noninfectious, as indicated by the absence of both IFA-positive cells and infectious viruses after transfection (Fig. 5) . Therefore, the results demonstrate that amino acids I311, T313, F314, and I317 from Site-311 play a critical role in EV71 replication.
Two distinct types of 3D pol mutants trans complement in vitro. Two types of trans complementation experiments were performed to explore the mechanism of EV71 VPg uridylylation.
Type one trans complementation was examined using one of the Site-311-defective mutants (I311A, T313A, F314A, or I317A) and a polymerase active site mutant (D238A). D238A lost its VPg uridylylation activity ( Fig. 2A) and RNA elongation (Fig. 3A) but retained the VPg binding activity (Fig. 4B) . Remarkably, incubation of mutant D238A plus mutant T313A, F314A, and I317A restored VPg uridylylation to approximately 20% to 88% of the wt activity ( Fig. 6A and B) . The combination of the D238A and I311A mutants showed 41% of the wt uridylylation activity (Fig. 6B) .The combination of D238A plus I311A did not improve the uridylylation activity over that seen with I311A alone, which retained 45% of the wt activity (Fig. 2) . As a control, the combined D238A and G316A mutants (fully competent in uridylylation) displayed 112% of the wt uridylylation activity. Overall, the results demonstrate that two distinct types of 3D pol mutants, i.e., polymerase active site and Site-311 mutants, trans complement in vitro.
Type two trans complementation was performed using two Site-311-defective mutants. The mutants T313A, F314A, and I317A were selected for the experiment because they exhibited Ͻ10% of the wt uridylylation activity (Fig. 2) . Interestingly, none of the two-mutant combinations (T313A plus F314A, T313A plus I317A, and F314A plus I317A) showed a significant improvement in VPg uridylylation (Fig. 7) . The results demonstrate that Site-311 mutants cannot trans complement each other in vitro.
Trans complementation of VPg uridylylation does not occur in vivo. The positive results of the type one trans complementation in vitro prompted us to examine whether such complementation could be achieved in vivo. Two genome-length RNAs, one containing a D238A mutation and another containing a I311A mutation, were cotransfected into Vero cells. The transfected cells were monitored for viral protein expression at various time points p.t. As shown in Fig. 6C , cells transfected with wt RNA alone produced an increased number of IFA-positive cells from 24 h to 48 h p.t. No IFA-positive cells were observed in the cells cotransfected with D238A and I311A RNA (Fig. 6C) . Similar negative results were observed after the cells were cotransfected with D238A and I313A RNA (data not shown). The results indicate that trans complementation of VPg uridylylation did not occur in vivo. The discrepancy between the in vitro complementation and in vivo trans complementation could have been caused by the compartmentalization of the replication complex inside the cell. Therefore, the exchange of 3D pol molecules is unlikely to occur in the context of a replication complex in vivo.
DISCUSSION
The replication of a picornavirus results from VPg uridylylation, generating a protein primer by linking two UMPs to the third tyrosine residue of the virally encoded protein VPg by RdRp. The crystal structures of FMDV and CVB3 3D pol in complex with their corresponding VPg revealed two distinct VPg binding sites in a picornavirus, although sequences of both 3D pol and VPg showed high similarity (6, 8) . We recently determined the crystal structure of EV71 3D pol in the absence of VPg (26) . In the current study, we performed a structure-guided mutagenesis analysis to investigate EV71 VPg binding and VPg uridylylation. The biochemical and virological analyses uncovered a novel site (Site-311) located at the base of the palm domain of EV71 3D pol , which is essential for VPg uridylylation and viral replication. As summarized in Table 1 , Ala substitutions at I311, T313, F314, and I317 significantly reduced VPg uridylylation and abolished viral replication, whereas other mutations within Site-311 retained VPg uridylylation and viral replication. The VPg uridylylation activity in vitro correlated well with the levels of viral replication in vivo, which suggests that , not detectable. Viral titers were calculated as the number of PFU per microliter using plaque assays, which were performed using a standard protocol, as mentioned in Materials and Methods.
the observed defect in viral replication was due to the defect in VPg uridylylation. Site-311 mutations potentially affect two processes required for VPg uridylylation. The mutations reduce polymerase activity or VPg binding to 3D pol . To differentiate between the two modes of action, we analyzed the mutants using both RNA elongation and VPg-3D pol pulldown assays. The results clearly show that Site-311 mutations reduced VPg binding to 3D pol (Fig. 4) , which suggests that Site-311 is a potential location for VPg binding. This notion is further supported by a detailed structure analysis of Site-311 (see below). However, our current data do not completely exclude the possibility that VPg binds to 3D pol at a location outside Site-311. In this case, mutations at Site-311 may indirectly affect the actual VPg binding site, leading to reduced VPg-3D pol interaction.
Site-311 comprises seven residues, among which three are hydrophobic (I311, F314, and I317), two are positively charged (K312 and K315), and one has a polar side chain (T313) (Fig. 8A) . Amino acids I311, T313, F314, and I317 form a circular and relatively hydrophobic cleft on the surface of EV71 3D pol . In contrast, The IFA results of analysis of the wild type, the D238A mutant, the I311A mutant, and D238A combined with I311A. Vero cells were transfected with the wt and mutant genome-length RNAs (2.5 g each) and analyzed for viral VP1 protein expression using IFA at 48 h p.t. 
Summary of mutagenesis analysis of the effect of Site-311 on EV71 replication resulting from its affecting the interaction between 3D pol and VPg. The replication levels of wildtype (WT) and mutant RNAs are categorized as nonreplicative (Ϫ), weak (ϩ/Ϫ), medium (ϩϩ), and strong (ϩϩϩϩ) based on the IFA results. The binding affinities between 3D
pol mutants and VPg are summarized as weak (ϩ/Ϫ) and strong (ϩϩϩϩ).
the hydrophilic side chain of K315 is exposed to the solvent and residue K312 is buried in the molecular folding (Fig. 8B ). This finding suggests that these two residues may not contribute to VPg binding. Consistent with the molecular features of Site-311, the I311A, T313A, F314A, and I317A mutants significantly decreased VPg binding to 3D pol , whereas the K312A, K315A, and G316A mutants did not affect the VPg-3D pol interaction (Fig. 4) . Another interesting feature was that the major cave in Site-311 was mainly formed by hydrophobic residues, indicating that Site-311 may make contact with and stabilize the hydrophobic residue(s) of EV71 VPg. Three hydrophobic groups, Tyr3, Val10-Leu11, and Leu16, were found in EV71 VPg (Fig. 8C) . Considering that Tyr3 is the priming residue for the VPg uridylylation reaction, this residue is unlikely to be captured by Site-311. Val10 and Leu11 were the most unconserved residues of VPg from different picornaviruses, whereas Leu16 was highly conserved (Leu, Val, or Ile) (Fig. 8C) . Given the variations in the VPg binding site of the Picornaviridae family, Site-311 probably interacts with the residues Val10-Leu11 or Pro14-Leu16 of EV71 VPg. To test whether the hydrophobic residues in VPg affect their interaction with EV71 3D pol , we constructed a few VPg mutants, including L11A, P14F, P14L, L16A, and R17A. The result of the GST-pulldown assay shows that these mutants attenuate the interaction between 3D pol and the VPg molecule, which supports our hypothesis (Fig. 8D) . Among these mutants, P14F significantly affected 3D pol -VPg, which suggests that this position may play a pivotal role in VPg binding. Hence, the detailed structure of EV71 3D polVPg is necessary to finalize these biochemical observations. Site-311 is Ͼ80 Å away from the catalytic site (measured as the distance on the molecular surface, not as the direct distance between the two sites) centered at D238 (Fig. 8E) . If Site-311 is the genuine VPg binding site, then the 3D pol molecule that carries VPg could not intramolecularly catalyze the uridylylation reaction. Instead, EV71 3D pol needs to employ an intermolecular mechanism for VPg uridylylation, i.e., one 3D pol molecule binds and projects VPg to the polymerase catalytic site of another 3D pol molecule for VPg uridylylation. The idea of such an intermolecular mechanism of EV71 VPg uridylylation is supported by the in vitro trans complementation results (Fig. 6A and B) . Specifically, a polymerase with a Site-311 mutation trans complements with a polymerase with an active site mutation to restore uridylylation. Under this condition, the polymerase with the active site mutation carries The EV71  3D pol molecule is presented as a white ribbon, and the residues in Site-311 are shown as red sticks. The distance from Site-311 to the catalytic center along the molecular surface is indicated by a red line.
VPg and presents the hydroxyl group of Tyr3 of VPg to the polymerase active site of the Site-311 mutant, which in return catalyzes the uridylylation reaction. The idea of an intermolecular mechanism was further supported by the observation that two Site-311 mutants did not trans complement because neither of the mutants efficiently binds or carries VPg. Our results are consistent with an intermolecular model previously proposed for CVB3 VPg (8), although CVB3 VPg and EV71 VPg bind to different sites on 3D pol molecules. The mutants on the corresponding residues of CVB3 VPg binding sites on EV71 3D
pol (e.g., W369A, G379A, E383A, and T392A) notably showed no defects in EV71 VPg binding and uridylylation (data not shown). Based on these results, Site-311 could be the binding site for VPg in EV71. We have recently obtained the crystal structure of EV71 3D pol in the VPg complex. The crystal structure clearly demonstrates that Site-311 of EV71 3D pol is involved in direct binding to VPg. The details of the structural information and the functional relevance of the structure are under investigation. Moreover, the current structural model for the poliovirus uridylylation complex has the polymerase interacting with a dimer of 3C (17) . Site-311 in EV71 3D pol may act as the binding site to stabilize the replication complex through interaction with a dimerized 3BC molecule.
Although our findings provide evidence of a new potential binding site of VPg on EV71 3D
pol , a few additional assays are still necessary to finalize knowledge of the variations of the VPg uridylylation mechanism among members of the picornavirus family. First, an in vitro VPg uridylylation assay using polymerase, VPg peptide, and a cre template represents an ideal system. However, the precise cre sequence in EV71 has not been experimentally defined, although it was predicted previously (5). Moreover, we have not yet been able to obtain the cre RNA in our laboratory, and thus we used poly(A) as the template for the VPg uridylylation assays in this work. Furthermore, 3CD may serve as the cofactor and play an important role during VPg uridylylation as we mentioned in the introduction above, although the exact mechanism remains unknown. 3CD possibly participates in VPg binding and 3D uridylylation in our proposed bimolecular 3D mechanisms. This possibility does not contradict our conclusion that one 3D pol is used for VPg binding and another 3D molecule is used for VPg uridylylation. In future studies, we plan to use 3CD/3D/VPg/cre RNA for VPg uridylylation and the crystal structure of 3D pol -VPg (or 3D pol -3BC or 3CD-VPg) to clarify this point.
In summary, the current study identified Site-311 as a potential VPg binding site on EV71 3D
pol . EV71 VPg uridylylation likely requires two 3D pol molecules. EV71 is one of the major viral pathogens in Asia, particularly in China. No antiviral treatment for EV71 infection is currently available. Vaccine development and viral protease 3C pro inhibitors have been reported for rEV71 (4, 10, 23, 25) . The results of the current study suggest that blockage of Site-311 by either chemical compounds or peptides derived from EV71 VPg potentially inhibits EV71 VPg-3D pol interaction and suppresses viral replication.
